NewslettersPulmonary Cell NewsIn Vitro Activity of Imipenem/Relebactam against Pseudomonas aeruginosa Isolated from Patients with Cystic FibrosisBy Noshin Noorjahan - October 31, 20230161The in vitro activity of imipenem/relebactam and imipenem was compared with other antipseudomonal antibiotics against 105 isolates from patients with CF from three US hospitals.[Antimicrobial Agents and Chemotherapy]Abstract